MDR1 C3435T polymorphism and interaction with environmental factors in risk of Parkinson's disease: A case-control study in Japan

Drug Metabolism and Pharmacokinetics

Volumn 28, Issue 2, 2013, Pages 138-143

  Kiyohara, Chikako ^a   Miyake, Yoshihiro ^b   Koyanagi, Midori ^b   Fujimoto, Takahiro ^b   Shirasawa, Senji ^b   Tanaka, Keiko ^b   Fukushima, Wakaba ^c   Sasaki, Satoshi ^d   Tsuboi, Yoshio ^b   Yamada, Tatsuo ^b   Oeda, Tomoko ^e   Shimada, Hiroyuki ^c   Kawamura, Nobutoshi ^a   Sakae, Nobutaka ^a   Fukuyama, Hidenao ^f   Hirota, Yishio ^c   Nagai, Masaki ^g  

^a KYUSHU UNIVERSITY   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

^c OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e UTANO NATIONAL HOSPITAL   (Japan)

^f KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Alcohol use; Epidemiology; Gene environment interaction; Multidrug resistance 1; Parkinson's disease; Pesticide use; Smoking

Indexed keywords

PESTICIDE;

ADULT; AGED; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; ENVIRONMENTAL FACTOR; FEMALE; GENETIC SUSCEPTIBILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MDR1 GENE; OCCUPATIONAL EXPOSURE; PARKINSON DISEASE; SMOKING;

EID: 84876779726     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.DMPK-12-RG-075     Document Type: Article

References (37)

1. Cordon-Cardo, C., O'Brien, J. P., Casals, D., Rittman-Grauer, L., Biedler, J. L., Melamed, M. R. and Bertino, J. R.: Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc. Natl. Acad. Sci. USA, 86: 695-698 (1989).
2. Gottesman, M. M. and Pastan, I.: Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem., 62: 385-427 (1993).
3. Schinkel, A. H., Wagenaar, E., van Deemter, L., Mol, C. A. and Borst, P.: Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J. Clin. Invest., 96: 1698-1705 (1995).
4. Mayer, U., Wagenaar, E., Beijnen, J. H., Smit, J. W., Meijer, D. K., van Asperen, J., Borst, P. and Schinkel, A. H.: Substantial excretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdr 1a P-glycoprotein. Br. J. Pharmacol., 119: 1038-1044 (1996).
5. Schinkel, A. H., Mayer, U., Wagenaar, E., Mol, C. A., van Deemter, L., Smit, J. J., van der Valk, M. A., Voordouw, A. C., Spits, H., van Tellingen, O., Zijlmans, J. M., Fibbe, W. E. and Borst, P.: Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc. Natl. Acad. Sci. USA, 94: 4028-4033 (1997).
6. Kim, R. B., Fromm, M. F., Wandel, C., Leake, B., Wood, A. J., Roden, D. M. and Wilkinson, G. R.: The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J. Clin. Invest., 101: 289-294 (1998).
7. Hoffmeyer, S., Burk, O., von Richter, O., Arnold, H. P., Brockmoller, J., Johne, A., Cascorbi, I., Gerloff, T., Roots, I., Eichelbaum, M. and Brinkmann, U.: Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc. Natl. Acad. Sci. USA, 97: 3473-3478 (2000).
8. Wang, D., Johnson, A. D., Papp, A. C., Kroetz, D. L. and Sadee, W.: Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability. Pharmacogenet. Genomics, 15: 693-704 (2005).
9. Fung, K. L. and Gottesman, M. M.: A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function. Biochim. Biophys. Acta, 1794: 860-871 (2009).
10. Furuno, T., Landi, M. T., Ceroni, M., Caporaso, N., Bernucci, I., Nappi, G., Martignoni, E., Schaeffeler, E., Eichelbaum, M., Schwab, M. and Zanger, U. M.: Expression polymorphism of the blood-brain barrier component P-glycoprotein (MDR1) in relation to Parkinson's disease. Pharmacogenetics, 12: 529-534 (2002).
11. Momose, Y., Murata, M., Kobayashi, K., Tachikawa, M., Nakabayashi, Y., Kanazawa, I. and Toda, T.: Association studies of multiple candidate genes for Parkinson's disease using single nucleotide polymorphisms. Ann. Neurol., 51: 133-136 (2002).
12. Droździk, M., Bialecka, M., Mysliwiec, K., Honczarenko, K., Stankiewicz, J. and Sych, Z.: Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease. Pharmacogenetics, 13: 259-263 (2003).
13. Tan, E. K., Drozdzik, M., Bialecka, M., Honczarenko, K., Klodowska-Duda, G., Teo, Y. Y., Tang, K., Wong, L. P., Chong, S. S., Tan, C., Yew, K., Zhao, Y. and Lee, C. G.: Analysis of MDR1 haplotypes in Parkinson's disease in a white population. Neurosci. Lett., 372: 240-244 (2004).
14. Zschiedrich, K., Konig, I. R., Bruggemann, N., Kock, N., Kasten, M., Leenders, K. L., Kostic, V., Vieregge, P., Ziegler, A., Klein, C. and Lohmann, K.: MDR1 variants and risk of Parkinson disease. Association with pesticide exposure? J. Neurol., 256: 115-120 (2009).
15. Lee, C. G., Tang, K., Cheung, Y. B., Wong, L. P., Tan, C., Shen, H., Zhao, Y., Pavanni, R., Lee, E. J., Wong, M. C., Chong, S. S. and Tan, E. K.: MDR1, the blood-brain barrier transporter, is associated with Parkinson's disease in ethnic Chinese. J. Med. Genet., 41: e60 (2004).
16. Tan, E. K., Chan, D. K., Ng, P. W., Woo, J., Teo, Y. Y., Tang, K., Wong, L. P., Chong, S. S., Tan, C., Shen, H., Zhao, Y. and Lee, C. G.: Effect of MDR1 haplotype on risk of Parkinson disease. Arch. Neurol., 62: 460-464 (2005).
17. Ritz, B., Ascherio, A., Checkoway, H., Marder, K. S., Nelson, L. M., Rocca, W. A., Ross, G. W., Strickland, D., Van Den Eeden, S. K. and Gorell, J.: Pooled analysis of tobacco use and risk of Parkinson disease. Arch. Neurol., 64: 990-997 (2007).
18. Priyadarshi, A., Khuder, S. A., Schaub, E. A. and Shrivastava, S.: A meta-analysis of Parkinson's disease and exposure to pesticides. Neuro-toxicology, 21: 435-440 (2000).
19. Ishihara, L. and Brayne, C.: A systematic review of nutritional risk factors of Parkinson's disease. Nutr. Res. Rev., 18: 259-282 (2005).
20. Elbaz, A. and Moisan, F.: Update in the epidemiology of Parkinson's disease. Curr. Opin. Neurol., 21: 454-460 (2008).
21. Hughes, A. J., Daniel, S. E., Kilford, L. and Lees, A. J.: Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry, 55: 181-184 (1992).
22. Miyake, Y., Sasaki, S., Tanaka, K., Fukushima, W., Kiyohara, C., Tsuboi, Y., Yamada, T., Oeda, T., Miki, T., Kawamura, N., Sakae, N., Fukuyama, H., Hirota, Y. and Nagai, M.: Dietary fat intake and risk of Parkinson's disease: a case-control study in Japan. J. Neurol. Sci., 288: 117-122 (2010).
23. Andersson, T., Alfredsson, L., Kallberg, H., Zdravkovic, S. and Ahlbom, A.: Calculating measures of biological interaction. Eur. J. Epidemiol., 20: 575-579 (2005).
24. Riegelman, R. K.: Interpretation. Studying a Study and Testing a Test: How to Read the Medical Evidence Fifth Edition. Philadelphia, Lippincott Williams & Wilkins, 2004, pp. 50-57.
25. NCBI: NCBI Single Nucleotide Polymorphism; [cited 2011]; Available from: http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1045642.
26. Komoto, C., Nakamura, T., Sakaeda, T., Kroetz, D. L., Yamada, T., Omatsu, H., Koyama, T., Okamura, N., Miki, I., Tamura, T., Aoyama, N., Kasuga, M. and Okumura, K.: MDR1 haplotype frequencies in Japanese and Caucasian, and in Japanese patients with colorectal cancer and esophageal cancer. Drug Metab. Pharmacokinet., 21: 126-132 (2006).
27. Osuga, T., Sakaeda, T., Nakamura, T., Yamada, T., Koyama, T., Tamura, T., Aoyama, N., Okamura, N., Kasuga, M. and Okumura, K.: MDR1 C3435T polymorphism is predictive of later onset of ulcerative colitis in Japanese. Biol. Pharm. Bull., 29: 324-329 (2006).
28. NCBI: NCBI Single Nucleotide Polymorphism; [cited 2011]; Available from: http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2229107.
29. Hunter, D. J.: Gene-environment interactions in human diseases. Nat. Rev. Genet., 6: 287-298 (2005).
30. Abu-Qare, A. W., Elmasry, E. and Abou-Donia, M. B.: A role for P-glycoprotein in environmental toxicology. J. Toxicol. Environ. Health B Crit. Rev., 6: 279-288 (2003).
31. Ebert, B., Seidel, A. and Lampen, A.: Identification of BCRP as transporter of benzo[a]pyrene conjugates metabolically formed in Caco-2 cells and its induction by Ah-receptor agonists. Carcinogenesis, 26: 1754-1763 (2005).
32. Vaché, C., Camares, O., De Graeve, F., Dastugue, B., Meiniel, A., Vaury, C., Pellier, S., Leoz-Garziandia, E. and Bamdad, M.: Drosophila melanogaster p-glycoprotein: a membrane detoxification system toward polycyclic aromatic hydrocarbon pollutants. Environ. Toxicol. Chem., 25: 572-580 (2006).
33. Shibata, N., Kageyama, M., Kimura, K., Tadano, J., Hukushima, H., Namiki, H., Yoshikawa, Y. and Takada, K.: Evaluation of factors to decrease plasma concentration of an HIV protease inhibitor, saquinavir in ethanol-treated rats. Biol. Pharm. Bull., 27: 203-209 (2004).
34. Patrick, D. L., Cheadle, A., Thompson, D. C., Diehr, P., Koepsell, T. and Kinne, S.: The validity of self-reported smoking: a review and meta-analysis. Am. J. Public Health, 84: 1086-1093 (1994).
35. Wells, A. J., English, P. B., Posner, S. F., Wagenknecht, L. E. and Perez-Stable, E. J.: Misclassification rates for current smokers mis-classified as nonsmokers. Am. J. Public Health, 88: 1503-1509 (1998).
36. Hilton, M. E.: A comparison of a prospective diary and two summary recall techniques for recording alcohol consumption. Br. J. Addict., 84: 1085-1092 (1989).
37. Midanik, L. T.: Perspectives on the validity of self-reported alcohol use. Br. J. Addict., 84: 1419-1423 (1989).